Mariateresa Fulciniti, Ph.D.
Co-Authors are people in Profiles who have published together.
Co-Authors are listed by decreasing relevence which is based on the number of co-publications and the years which they were written.
| Name |
Most Recent
Co-Publication
|
Number of
Co-Publications
| Co-Author Score |
Why?
|
|---|
| Nikhil C Munshi, M.B.,B.S., M.D. | 2024 | 74 | 8.140 |
Why?
|
| Kenneth Carl Anderson, M.D. | 2024 | 54 | 4.570 |
Why?
|
| Mehmet Kemal Samur, Ph.D. | 2024 | 29 | 2.700 |
Why?
|
| Rao H Prabhala, Ph.D. | 2024 | 14 | 1.280 |
Why?
|
| Teru Hideshima, M.D., Ph.D. | 2024 | 23 | 0.940 |
Why?
|
| Paul Gerard Guy Richardson, M.B.,B.S. | 2024 | 21 | 0.930 |
Why?
|
| Anil Aktas Samur, Ph.D. | 2023 | 9 | 0.750 |
Why?
|
| Steven P. Treon, M.D., Ph.D. | 2024 | 10 | 0.710 |
Why?
|
| Raphael E Szalat, M.D. | 2023 | 10 | 0.700 |
Why?
|
| Ruben D. Carrasco, M.D., Ph.D. | 2024 | 7 | 0.610 |
Why?
|
| Dharminder Chauhan, J.D., Ph.D. | 2024 | 14 | 0.600 |
Why?
|
| Zachary Richard Hunter, Ph.D. | 2024 | 8 | 0.550 |
Why?
|
| Noopur Raje, M.D. | 2022 | 10 | 0.530 |
Why?
|
| Adam Samuel Sperling, M.D.,Ph.D. | 2023 | 6 | 0.390 |
Why?
|
| Giovanni Parmigiani, Ph.D. | 2023 | 8 | 0.360 |
Why?
|
| Constantine S Mitsiades, M.D., Ph.D. | 2024 | 3 | 0.330 |
Why?
|
| Srikanth Talluri, Ph.D. | 2024 | 5 | 0.270 |
Why?
|
| Debasmita Dutta, Ph.D. | 2023 | 1 | 0.240 |
Why?
|
| Ting Du, Ph.D. | 2023 | 1 | 0.230 |
Why?
|
| Giada Bianchi, M.D. | 2024 | 4 | 0.220 |
Why?
|
| Sophia Adamia, Ph.D. | 2019 | 2 | 0.210 |
Why?
|
| Shayna Rae Sarosiek, M.D. | 2021 | 1 | 0.210 |
Why?
|
| Benjamin L. Ebert, D.Phil., M.D. | 2019 | 1 | 0.180 |
Why?
|
| Christopher John Ott, Ph.D. | 2018 | 1 | 0.170 |
Why?
|
| Jason Samuel Gold, M.D. | 2015 | 1 | 0.140 |
Why?
|
| David Scadden, M.D. | 2013 | 3 | 0.130 |
Why?
|
| Johany Penailillo, Ph.D. | 2024 | 2 | 0.120 |
Why?
|
| Domenico Maisano, Ph.D. | 2024 | 2 | 0.120 |
Why?
|
| Scott J. Rodig, M.D., Ph.D. | 2011 | 1 | 0.100 |
Why?
|
| Diana Cirstea, M.D. | 2013 | 4 | 0.100 |
Why?
|
| Irene Ghobrial, M.D. | 2022 | 3 | 0.100 |
Why?
|
| Jarrod Marto, Ph.D. | 2024 | 2 | 0.100 |
Why?
|
| Catherine Ju-Ying Wu, M.D. | 2024 | 2 | 0.100 |
Why?
|
| Scott Ficarro, Ph.D. | 2024 | 2 | 0.100 |
Why?
|
| Geraldine Sowinski Pinkus, M.D. | 2024 | 2 | 0.100 |
Why?
|
| David Michael Dorfman, M.D.,Ph.D. | 2024 | 2 | 0.100 |
Why?
|
| Shuhui Deng, Ph.D. | 2020 | 2 | 0.090 |
Why?
|
| Vanessa Favasuli, Ph.D. | 2024 | 1 | 0.060 |
Why?
|
| Arghya Ray, Ph.D. | 2023 | 1 | 0.060 |
Why?
|
| Xueping Wan, Ph.D. | 2023 | 1 | 0.060 |
Why?
|
| Massimo Loda, M.D. | 2023 | 1 | 0.060 |
Why?
|
| Carl D Novina, M.D., Ph.D. | 2023 | 1 | 0.060 |
Why?
|
| Jacob Laubach, M.D. | 2022 | 1 | 0.050 |
Why?
|
| Andrew J. Yee, M.D. | 2022 | 1 | 0.050 |
Why?
|
| Omar Nadeem, M.D. | 2022 | 1 | 0.050 |
Why?
|
| Chandraditya Chakraborty, Ph.D. | 2020 | 1 | 0.050 |
Why?
|
| Dominik Glodzik, Ph.D. | 2019 | 1 | 0.050 |
Why?
|
| Peter Grant Miller, M.D. | 2019 | 1 | 0.040 |
Why?
|
| Anthony George Letai, M.D., Ph.D. | 2019 | 1 | 0.040 |
Why?
|
| Emma Catherine Fink, M.D. | 2019 | 1 | 0.040 |
Why?
|
| Max Jan, M.D.,Ph.D. | 2019 | 1 | 0.040 |
Why?
|
| Raj K. Goyal, M.B.,B.S., M.D. | 2010 | 2 | 0.040 |
Why?
|
| Jeffrey Michael Karp, Ph.D. | 2017 | 1 | 0.040 |
Why?
|
| Bisweswar Nandi, Ph.D. | 2015 | 1 | 0.030 |
Why?
|
| Henry Morris Kronenberg, M.D. | 2013 | 1 | 0.030 |
Why?
|
| Loren David Walensky, M.D.,Ph.D. | 2012 | 1 | 0.030 |
Why?
|
| Ramesh Shivdasani, M.D.,Ph.D. | 2012 | 1 | 0.030 |
Why?
|
| Gregory Bird, Ph.D. | 2012 | 1 | 0.030 |
Why?
|
| Jeremy Adam Ryan, S.M. | 2012 | 1 | 0.030 |
Why?
|
| Maureen French, M.D. | 2012 | 1 | 0.030 |
Why?
|
| Martin Sattler, Ph.D. | 2011 | 1 | 0.030 |
Why?
|
| Aliyah R. Sohani, M.D. | 2010 | 1 | 0.020 |
Why?
|
| Ralph Weissleder, M.D., Ph.D. | 2010 | 1 | 0.020 |
Why?
|
| Edie A. Weller Toolan, Ph.D. | 2010 | 1 | 0.020 |
Why?
|
| Mary Larsen Bouxsein, Ph.D. | 2008 | 1 | 0.020 |
Why?
|
| Marc Nathan Wein, M.D.,Ph.D. | 2008 | 1 | 0.020 |
Why?
|
| Laurie Hollis Glimcher, M.D. | 2008 | 1 | 0.020 |
Why?
|
| Josh Aronson, M.D. | 2008 | 1 | 0.020 |
Why?
|